SARs has long been used to design chemicals with commercially desirable properties with expected pharmacologic and therapeutic activities. Moreover, computer-based modeling methods, as well as AI-driven approaches relating chemical structure to qualitative biological activity and quantitative biological potency have been widely applied in diverse problem settings. CD ComputaBio provides intelligent services of structure activity relationship analysis and development for our clients in different stage of drug discovery, especially for screening large numbers of chemicals and decision making during chemical optimization.
https://ai.computabio.com/...

Only people mentioned by VivianSmith in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Vivian Smith, click on at the bottom under it